Atai Life Sciences, a Peter Thiel-backed company that produces psychedelic and non-psychedelic mushroom-based therapies for depression and anxiety, is now publicly available on the Nasdaq. Read on to learn how to buy Atai Life Sciences from Canada.
How to buy Atai Life Sciences stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ATAI. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
Interactive Brokers
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
What's in this guide?
Atai Life Sciences stock price (NASDAQ:ATAI)
Use our graph to track the performance of ATAI stocks over time.Atai Life Sciences shares at a glance
Latest market close | $1.77 |
---|---|
52-week range | $1.14 - $4.96 |
50-day moving average | $1.79 |
200-day moving average | $2.60 |
Wall St. target price | $13.15 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.89 |
Buy Atai Life Sciences stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Atai Life Sciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Atai Life Sciences price performance over time
Historical closes compared with the close of $1.77 from 2023-05-26
1 week (2023-05-19) | -5.85% |
---|---|
1 month (2023-04-28) | -7.33% |
3 months (2023-02-28) | 5.36% |
6 months (2022-11-25) | -42.72% |
1 year (2022-05-25) | -53.91% |
---|---|
2 years (2021-05-24) | N/A |
3 years (2020-05-24) | N/A |
5 years (2018-05-24) | N/A |
Atai Life Sciences financials
Revenue TTM | $233,000 |
---|---|
Gross profit TTM | $233,000 |
Return on assets TTM | -25.09% |
Return on equity TTM | -48.31% |
Profit margin | 0% |
Book value | $1.57 |
Market capitalisation | $293.8 million |
TTM: trailing 12 months
Atai Life Sciences share dividends
We're not expecting Atai Life Sciences to pay a dividend over the next 12 months.
Atai Life Sciences overview
Atai Life Sciences N. V. , through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA neurotransmitter systems to treat cognitive impairment associated with schizophrenia; DMX-1002, an oral formulation of ibogaine for treating opioid use disorder (OUD); GRX-917, an oral formulation of a deuterated version of etifoxine for the anxiety-related disorder treatment; and Neuronasal, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01, a formulation of N,N-dimethyltryptamine for treating TRD; EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder; RLS-01 for TRD; and KUR-101, a formulation of deuterated mitragynine to treat OUD. The company was formerly known as Adripa Holding B.
Stocks similar to Atai Life Sciences
Atai Life Sciences in the news
atai Life Sciences legt Finanzergebnisse für das erste Quartal 2023 vor und gibt Highlights und Updates zur Pipeline bekannt
atai Life Sciences Reports First Quarter 2023 Financial Results and Announces Pipeline Highlights and Updates
atai Life Sciences ist Teilnehmer der im Mai stattfindenden Investorenkonferenz
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing

How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
Best stock app for beginners for 2023
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…More guides on Finder
-
Guide to finding the best prepaid card in Canada in May 2023
We show you the best prepaid credit cards in Canada, whether you’re looking for a prepaid card with no fees, cash back rewards, or travel perks, or more.
-
How to buy Sui (SUI) in Canada
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
-
5 apps like Nyble in Canada
Compare apps like Nyble in Canada to access emergency funding.
-
RightRide review
Your guide to buying and financing a car in Canada with RightRide.
-
Compare bad credit car loans in BC
Your guide to bad credit car loans in BC and how to find the right financing for your needs.
-
Camera financing in Canada
Compare six ways to finance a camera in Canada, including options for good and bad credit.
-
How to buy Pepe (PEPE) in Canada
This guide provides step-by-step instructions on how to buy Pepe, lists some exchanges where you can get it and provides daily price data on (PEPE).
-
Personal loans in Saskatchewan up to $50,000
Compare lenders to find the best personal loan in Saskatchewan for your needs.
-
Compare bad credit loans in Winnipeg
Compare interest rates and eligibility requirements of bad credit loans in Winnipeg.
-
Money Management for Teens: 7 Tips from Financial Experts
Teaching teenagers how to budget can be a tricky task. 7 experts give their best tips on how to budget for teenagers.